For what solid tumors and hematologic malignancies has NGS genomic profiling shown to be most valuable for identifying disease alleles which can reliably guide the use of molecularly targeted therapy?

For what solid tumors and hematologic malignancies has NGS genomic profiling shown to be most valuable for identifying disease alleles which can reliably guide the use of molecularly targeted therapy?

For what specific solid tumors and hematologic malignancies has NGS genomic profiling shown to be most valuable for identifying disease alleles which can reliably guide the use of molecularly targeted therapy?

CLICK HERE FOR CME CREDIT

Created by

CMEducation Resources IQ&A Interactive Intelligence Zone

Presenter

Professsor Hyun Cheol Chung, MD

Professsor Hyun Cheol Chung, MD

Professor of Medical Oncology
Director, Yonsei Song-Dang Institute for Cancer Research
Yonsei University College of Medicine
Seoul, Korea